ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,798Medicare Part D Prescriptions Filled, Including Refills

Rank: 46 out of 288

$751K Total Retail Price of All Prescriptions

Rank: 17 out of 288

442 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
48% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Iowa
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

14% of this provider’s 442 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

1% of this provider’s 9,748 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

34% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$64 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Iowa
LEVOTHYROXINE SODIUM 433 376 1 2
PRAVASTATIN SODIUM 388 318 2 21
AMLODIPINE BESYLATE 359 340 3 6
LISINOPRIL 348 296 4 4
OMEPRAZOLE 329 249 5 3
ATORVASTATIN CALCIUM 290 261 6 14
SPIRIVA 274 167 7 48
FUROSEMIDE 251 231 8 5
HYDROCODONE-ACETAMINOPHEN 230 174 S3 9 7
PANTOPRAZOLE SODIUM 223 212 10 42
LOSARTAN POTASSIUM 218 173 11 16
METOPROLOL TARTRATE 204 200 12 8
METOPROLOL SUCCINATE 202 190 13 15
METFORMIN HCL 189 169 14 12
SYMBICORT 186 108 15 104
PROAIR HFA 177 99 16 45
ZETIA 172 160 17 58
POTASSIUM CHLORIDE 159 142 18 11
SIMVASTATIN 158 151 19 1
RANITIDINE HCL 155 86 20 33
TEKTURNA 153 123 21 225
WARFARIN SODIUM 152 137 22 9
ATENOLOL 147 133 23 10
SYNTHROID 145 133 24 63
ISOSORBIDE MONONITRATE ER 126 124 25 35
PLAVIX 123 118 26 71
FINASTERIDE 114 112 27 82
TAMSULOSIN HCL 114 112 27 24
ADVAIR DISKUS 112 77 29 50
GABAPENTIN 111 80 30 17
CLOPIDOGREL 109 102 31 47
CITALOPRAM HBR 107 76 32 18
SPIRONOLACTONE 104 73 33 36
DONEPEZIL HCL 101 96 34 29
CELEBREX 101 90 34 84
THEOPHYLLINE ANHYDROUS 99 48 36 174
PREDNISONE 94 76 37 30
SINGULAIR 94 56 37 86
CLONIDINE HCL 92 76 39 70
DILTIAZEM 24HR CD 90 82 40 75
NEXIUM 83 56 41 43
CRESTOR 78 75 42 26
COMBIVENT 77 46 43 124
FLOVENT HFA 77 43 43 202
AMLODIPINE BESYLATE-BENAZEPRIL 72 72 45 89
GLIMEPIRIDE 71 53 46 32
CARVEDILOL 68 52 47 27
NAMENDA 68 62 47 39
ALENDRONATE SODIUM 68 67 47 20
LIPITOR 66 46 50 107
NIFEDIPINE ER 66 66 50 140
DIGOXIN 64 64 52 51
TERAZOSIN HCL 63 63 53 85
ALLOPURINOL 61 56 54 23
ESCITALOPRAM OXALATE 61 51 54 87
HYDROCHLOROTHIAZIDE 60 57 56 13
AMITRIPTYLINE HCL 59 39 R 57 65
PRAMIPEXOLE DIHYDROCHLORIDE 58 47 58 122
FLUTICASONE PROPIONATE 58 38 58 41
ZOLPIDEM TARTRATE 54 46 60 22
LEVOFLOXACIN 52 42 61 80
POLYETHYLENE GLYCOL 3350 51 49 62 38
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 28, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.